Human papillomavirus (HPV) can drive tumor development in some rare sinonasal squamous cell carcinomas (SNSCCs), according to ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall survival (OS) analysis of the Phase III INAVO120 study. These data showed ...

AstraZeneca's camizestrant and Pfizer's vepdegestrant extended progression-free survival in trials in advanced ESR1-mutated breast cancer.

In mice, engineered immune cells shrink pancreatic and other tumours bearing a mutant version of the KRAS protein.

Her cancer tested positive for a mutation in the PIK3CA (phosphatidylinositol-4,5- bisphosphate 3-kinase catalytic subunit alpha) gene, which provides instructions for cells to make part of an ...

The ItovebiTM (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer, compared with palbociclib and fulve ...

A new COVID-19 variant called NB.1.8.1, aka "Nimbus," is spreading rapidly in the United States, CDC data show. What to know ...